Literature DB >> 8495019

BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route.

M Lagranderie1, P Ravisse, G Marchal, M Gheorghiu, V Balasubramanian, E H Weigeshaus, D W Smith.   

Abstract

Since studies on cellular immune responses have demonstrated the role of the mucosal lymphoid system of the respiratory tract, we have studied responses obtained from the local respiratory route, compared to the systemic intradermal route, of BCG immunization. Guinea pigs vaccinated with different doses of BCG via both routes served to follow lymphoid cell proliferation, hilar lymph node and lung BCG clearance, lung granuloma formation and protection induced after virulent challenge. Results demonstrate that the aerogenic route of vaccination with BCG has no harmful side-effects for the host. In comparison with the intradermal route of vaccination, aerogenic vaccination with 10(5) BCG cfu induced higher local cellular immune responses and a substantially improved protective effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495019     DOI: 10.1016/0962-8479(93)90067-8

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  20 in total

1.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Efficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization.

Authors:  Maytal Bivas-Benita; Liat Bar; Geoffrey O Gillard; David R Kaufman; Nathaniel L Simmons; Avi-Hai Hovav; Norman L Letvin
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Immunization by a bacterial aerosol.

Authors:  Lucila Garcia-Contreras; Yun-Ling Wong; Pavan Muttil; Danielle Padilla; Jerry Sadoff; Jessica Derousse; Willem Andreas Germishuizen; Sunali Goonesekera; Katharina Elbert; Barry R Bloom; Rich Miller; P Bernard Fourie; Anthony Hickey; David Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-14       Impact factor: 11.205

4.  Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.

Authors:  Nacho Aguilo; Ana Maria Toledo; Eva Maria Lopez-Roman; Esther Perez-Herran; Eamonn Gormley; Joaquin Rullas-Trincado; Iñigo Angulo-Barturen; Carlos Martin
Journal:  Clin Vaccine Immunol       Date:  2014-02-05

5.  Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.

Authors:  Steven C Derrick; Kristopher Kolibab; Amy Yang; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2014-08-20

6.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

7.  Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Authors:  Lihao Chen; Jun Wang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen.

Authors:  M Gheorghiu; M R Lagranderie; B M Gicquel; C D Leclerc
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice.

Authors:  Santiago Uranga; Dessislava Marinova; Carlos Martin; Nacho Aguilo
Journal:  J Vis Exp       Date:  2016-09-19       Impact factor: 1.355

10.  Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

Authors:  E L Nuermberger; T Yoshimatsu; S Tyagi; W R Bishai; J H Grosset
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.